Table 2 KEGG enrichment of hypermethylated and low expression genes (\(P<\)0.01)
Term | ID | P-Value |
|---|---|---|
Metabolic pathways | hsa01100 | 2.80e-4 |
Drug metabolism - cytochrome P450 | hsa00982 | 4.68e-4 |
Platinum drug resistance | hsa01524 | 4.81e-4 |
Metabolism of xenobiotics by cytochrome P450 | hsa00980 | 5.20e-4 |
Chemical carcinogenesis | hsa05204 | 6.02e-4 |
Small cell lung cancer | hsa05222 | 7.70e-4 |
Toxoplasmosis | hsa05145 | 1.12e-3 |
Pathways in cancer | hsa05200 | 1.47e-3 |
Fluid shear stress and atherosclerosis | hsa05418 | 1.68e-3 |
Focal adhesion | hsa04510 | 3.37e-3 |
Phenylalanine metabolism | hsa00360 | 7.77e-3 |
Primary bile acid biosynthesis | hsa00120 | 7.77e-3 |
PI3K-Akt signaling pathway | hsa04151 | 1.00e-2 |